ERJ Open Research (Apr 2019)
The characterisation of interstitial lung disease multidisciplinary team meetings: a global study
- Luca Richeldi,
- Naomi Launders,
- Fernando Martinez,
- Simon L.F. Walsh,
- Jeffrey Myers,
- Bonnie Wang,
- Mark Jones,
- Alison Chisholm,
- Kevin R. Flaherty,
- REG IPF/ILD Working Group collaborators:,
- Aileen David-Wang,
- Antonio Morais,
- Arata Azuma,
- Bruno Crestani,
- Carlo Vancheri,
- Carole Youakim,
- Charlene D. Fell,
- Christopher J. Ryerson,
- Demosthenes Bouros,
- Elisabeth Bendstrup,
- Ferran Morell,
- Francesco Bonella,
- Ganesh Raghu,
- George Christoff,
- Giovanni Ferrara,
- Ian Glaspole,
- Ivan Rosas,
- Jürgen Behr,
- Kaissa DeBoer,
- Katerina M. Antoniou,
- Keertan Dheda,
- Kevin Brown,
- Lurdes Planas-Cerezales,
- Magnus Sköld,
- Manuela Funke,
- Maria Molina-Molina,
- Mariano Mazzei,
- Martin Kolb,
- Moises Selman,
- Paola Rottoli,
- Paolo Spagnolo,
- Pilar Rivera-Ortega,
- Sergey Avdeev,
- Silvia Quandrelli,
- Tamera J. Corte,
- Toby M. Maher,
- Vincent Cottin,
- Wim Wuyts,
- Zuo Jun Xu
Affiliations
- Luca Richeldi
- Unità Operativa Complessa di Pneumologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy
- Naomi Launders
- Respiratory Effectiveness Group, Cambridge, UK
- Fernando Martinez
- Joan and Sanford I. Weill Dept of Medicine, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY, USA
- Simon L.F. Walsh
- Dept of Radiology, Royal Brompton Hospital, London, UK
- Jeffrey Myers
- Dept of Pathology, University of Michigan, Ann Arbor, MI, USA
- Bonnie Wang
- Division of Pulmonary and Critical Care Medicine, Dept of Medicine, University of Michigan, Ann Arbor, MI, USA
- Mark Jones
- NIHR Southampton Biomedical Research Centre, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK
- Alison Chisholm
- Respiratory Effectiveness Group, Cambridge, UK
- Kevin R. Flaherty
- Division of Pulmonary and Critical Care Medicine, Dept of Medicine, University of Michigan, Ann Arbor, MI, USA
- REG IPF/ILD Working Group collaborators:
- Aileen David-Wang
- Antonio Morais
- Arata Azuma
- Bruno Crestani
- Carlo Vancheri
- Carole Youakim
- Charlene D. Fell
- Christopher J. Ryerson
- Demosthenes Bouros
- Elisabeth Bendstrup
- Ferran Morell
- Francesco Bonella
- Ganesh Raghu
- George Christoff
- Giovanni Ferrara
- Ian Glaspole
- Ivan Rosas
- Jürgen Behr
- Kaissa DeBoer
- Katerina M. Antoniou
- Keertan Dheda
- Kevin Brown
- Lurdes Planas-Cerezales
- Magnus Sköld
- Manuela Funke
- Maria Molina-Molina
- Mariano Mazzei
- Martin Kolb
- Moises Selman
- Paola Rottoli
- Paolo Spagnolo
- Pilar Rivera-Ortega
- Sergey Avdeev
- Silvia Quandrelli
- Tamera J. Corte
- Toby M. Maher
- Vincent Cottin
- Wim Wuyts
- Zuo Jun Xu
- DOI
- https://doi.org/10.1183/23120541.00209-2018
- Journal volume & issue
-
Vol. 5,
no. 2
Abstract
Multidisciplinary team (MDT) diagnosis of interstitial lung disease (ILD) has been proposed as a gold standard, but there are no formal recommendations for MDT process or composition and limited knowledge regarding prevalence in routine practice. We performed a systematic evaluation of ILD diagnostic practice across a range of healthcare settings around the world. Electronic questionnaires were distributed across all global regions via society and collaborators networks. Responses from 457 unique centres across 64 countries were included in the analysis. Of the 350 (76.6%) centres holding formal meetings, the majority held face-to-face MDT meetings (80%), for a minimum of 30 min (93%), and discussed diagnosis (96.9%) and patient management (94.9%) at the meetings. Compared with non-academic and academic non-ILD centres, ILD academic centres reported a higher ILD caseload, held more formal MDT meetings, and were more likely to include histopathology and rheumatology specialists in their diagnostic team. Of the centres holding MDT meetings, 5.5% routinely discussed all new cases at such meetings. An MDT approach to ILD diagnosis is consistently interpreted and widely implemented across a range of routine care settings around the world. This observation will inform future ILD diagnostic agreement studies and diagnostic pathway recommendations.